Showing 501 - 520 results of 33,734 for search '(( 2 fold decrease ) OR ( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.23s Refine Results
  1. 501
  2. 502

    Heatmap of fold-changes of metabolites. by Elena Heidenreich (6940475)

    Published 2019
    “…<p>Fold-changes of metabolites in different pCO<sub>2</sub> (400 vs. 1000 μatm CO<sub>2</sub>) and light acclimations (LL vs. …”
  3. 503
  4. 504

    Regions (α-helices, β-sheets, and loops) showing an average increase or decrease of RMSF in the MTs compared to the WT; RMSF of a particular structure is taken to be increased or decreased if there is an average change in RMSF of >0.03 nm in at least ≥50% of its residues. by Kumaraswamy Naidu Chitrala (612025)

    Published 2014
    “…<p>Regions (α-helices, β-sheets, and loops) showing an average increase or decrease of RMSF in the MTs compared to the WT; RMSF of a particular structure is taken to be increased or decreased if there is an average change in RMSF of >0.03 nm in at least ≥50% of its residues.…”
  5. 505

    Resveratrol Prevents Oxidative Stress-Induced Senescence and Proliferative Dysfunction by Activating the AMPK-FOXO3 Cascade in Cultured Primary Human Keratinocytes by Yasuo Ido (172159)

    Published 2015
    “…In addition, we found that treatment of keratinocytes with Ex527, a specific inhibitor of sirtuin 1 (SIRT1), attenuated the ability of resveratrol to suppress senescence. …”
  6. 506
  7. 507
  8. 508
  9. 509
  10. 510
  11. 511

    S1 Dataset - by Nelmo Jordão Manjate (16324619)

    Published 2023
    “…This study aimed to estimate the cost of SARS-CoV-2 diagnosis of symptomatic suspected patients by reverse transcription polymerase chain reaction (RT-PCR) and antigen rapid diagnostic tests (Ag-RDT) in Mozambique. We conducted a retrospective cost analysis from the provider’s perspective using a bottom-up, micro-costing approach, and compared the direct costs of two nasopharyngeal Ag-RDTs (Panbio and Standard Q) against the costs of three nasal Ag-RDTs (Panbio, COVIOS and LumiraDx), and RT-PCR. …”
  12. 512
  13. 513
  14. 514

    Minimal dataset. by Jennifer M. Kwan (3350321)

    Published 2024
    “…Dual ICI therapy was also associated with a 2.0-fold increased risk of myo/pericarditis (<i>P</i> = 0.045), with myo/pericarditis being associated with a 2.9-fold increased risk of mortality (<i>P</i><0.001). …”
  15. 515
  16. 516
  17. 517
  18. 518
  19. 519
  20. 520